Rilotumumab

Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.

Product Specifications

CAS Number

872514-65-3

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

C-Met/HGFR

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

AM06058PU-N 50 µL

RPA14 (RPA3) (full length) Mouse Monoclonal Antibody [Clone ID: 111]

Ask

View Details

GWB-800B69 0.1 mg

ZNF582 Over-expression Lysate Product

Ask

View Details

MBS8551327-01 0.1 mL

KIAA1310 (Center) Rabbit pAb

Ask

View Details

MBS8551327-02 0.1 mL (AF405L)

KIAA1310 (Center) Rabbit pAb

Ask

View Details

MBS8551327-03 0.1 mL (AF405S)

KIAA1310 (Center) Rabbit pAb

Ask

View Details

MBS8551327-04 0.1 mL (AF610)

KIAA1310 (Center) Rabbit pAb

Ask

View Details